European Healthtech startup funding raised during January 2020.
In January 2020, 52 European Healthtech companies raised a combined €347M across 54 funding rounds, down 73.1% versus January 2019. Germany led by capital raised, and Ananda Impact Ventures was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Northsea Therapeutics | Series B | Jan 2020 | €36M |
| Merantix | Series A | Jan 2020 | €25M |
| Nanox Imaging | Other | Jan 2020 | €23M |
| Oviva | Series B |
| Jan 2020 |
| €19M |
| Alderaan Biotechnology | Series A | Jan 2020 | €19M |
| Geneuro | Other | Jan 2020 | €18M |
| Temedica | Series B | Jan 2020 | €17M |
| Radiaction | Series B | Jan 2020 | €16M |
| iOnctura | Series A | Jan 2020 | €15M |
| Cardiology Ai | Series A | Jan 2020 | €14M |
| Bioprotect | Series D+ | Jan 2020 | €12M |
| Heparegenix | Series B | Jan 2020 | €11M |
| Elder | Series B | Jan 2020 | €9.6M |
| Sensome | Series B | Jan 2020 | €8.0M |
| Doctrin | Series B | Jan 2020 | €7.9M |
